IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.814
NA - Nord America 7.040
AS - Asia 808
SA - Sud America 60
OC - Oceania 17
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.982
IE - Irlanda 2.396
IT - Italia 1.286
UA - Ucraina 1.266
GB - Regno Unito 958
DE - Germania 409
FR - Francia 385
CN - Cina 384
SE - Svezia 373
FI - Finlandia 327
GR - Grecia 255
TR - Turchia 253
VN - Vietnam 55
BR - Brasile 45
PL - Polonia 41
BE - Belgio 30
IN - India 29
CA - Canada 25
MX - Messico 24
NL - Olanda 22
KR - Corea 20
AU - Australia 17
IR - Iran 16
RU - Federazione Russa 16
PK - Pakistan 13
ES - Italia 12
JP - Giappone 12
AT - Austria 8
CZ - Repubblica Ceca 7
AR - Argentina 6
EC - Ecuador 6
MK - Macedonia 6
SG - Singapore 6
ID - Indonesia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
RO - Romania 4
EU - Europa 3
NO - Norvegia 3
TW - Taiwan 3
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
HK - Hong Kong 2
LT - Lituania 2
MY - Malesia 2
TH - Thailandia 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
MO - Macao, regione amministrativa speciale della Cina 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 15.752
Salva come PNG Salva come JPEG
Città #
Dublin 2.394
Jacksonville 1.918
Chandler 1.229
Princeton 378
Roxbury 311
Ann Arbor 225
Cambridge 220
Medford 169
Wilmington 159
Boardman 156
Beijing 147
Woodbridge 137
New York 130
Naples 96
Caserta 89
Des Moines 86
San Mateo 78
Houston 77
Mountain View 66
Nanjing 64
Bremen 61
Dong Ket 54
Ashburn 53
Rome 45
Napoli 40
Düsseldorf 39
Kraków 33
Brussels 30
Norwalk 28
Shenyang 27
Jinan 26
Milan 25
Potenza 25
Auburn Hills 21
Paris 18
Boydton 15
Nanchang 14
Sennori 14
Bari 13
Helsinki 13
Bologna 12
Redwood City 11
Salerno 11
Changsha 10
Jinju 10
Kunming 10
Venice 10
Aversa 9
Fairfield 9
Mexico 9
Atella 8
Catania 8
Cattolica 8
Florence 8
Groningen 8
Hanover 8
Los Angeles 8
Ottawa 8
Tianjin 8
Vienna 8
Haikou 7
Hebei 7
Lanzhou 7
Pescara 7
Porto Alegre 7
Seregno 7
Zhengzhou 7
Amsterdam 6
Hyderabad 6
Lahore 6
Madrid 6
Orange 6
Portici 6
São Paulo 6
Torino 6
Bacoli 5
Bovisio 5
Brighton 5
Brno 5
Daejeon 5
Hangzhou 5
Jiaxing 5
Lappeenranta 5
Lissone 5
London 5
Nola 5
Quito 5
San Mango 5
Shanghai 5
Thessaloniki 5
Berlin 4
Dallas 4
Falls Church 4
Hadishahr 4
Modena 4
Moscow 4
Ningbo 4
Palermo 4
Pavia 4
Philadelphia 4
Totale 9.116
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 136
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 103
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 102
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 100
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 100
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 99
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 99
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 99
Intrafamilial spread of Helicobacter pylori infection 88
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 86
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 85
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 84
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 84
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 79
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 73
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 72
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 71
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 70
Chronic inflammation and oxidative stress in human carcinogenesis 70
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 70
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 70
Alteration of haemostasis in non-metastatic gastric cancer 68
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 68
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 67
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 67
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 67
The role of a probiotic (FLORTEC, Bracco S.p.A., Italy) on the plasma levels and peripheral blood mononuclear cell expression of cytokines in patients with ulcerative colitis: a pilot study. 66
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 66
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 64
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 64
A case of hepatotoxicity caused by green tea 63
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 63
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 62
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 62
The Role of Stress in Inflammatory Bowel Diseases 62
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 62
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 61
Rapporti fra alimentazione e stato nutrizionale in pazienti con cirrosi epatica. 61
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 61
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 60
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 60
Sequential therapy for eradication of Helicobacter pilori infection 60
Crohn’s disease and skin 59
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 59
Effetti di un nuovo composto farmaceutico (Sillibina, fosfolipidi e vitamina E) sulla protezione del danno prodotto dall’alcol su cellule di adenocarcinoma gastrico MKN-28. 59
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 59
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 59
Trace elements and chronic liver diseases 58
Le abitudini alimentari influenzano i livelli plasmatici di aminoacidi e oligoelementi nel paziente cirrotico? 58
Valutazione dell’effetto di silibina+fosfatidilcolina+vitamina E vs placebo sul danno epatico in pazienti con NAFLD (nonalcoholic fatty liver disease): risultati di un trial clinico europeo randomizzato in doppio cieco. 58
La steatoepatite non alcolica (NAFLD): studio multicentrico italiano. 58
Tiroidite autoimmune in corso di trattamento con IFN in pazienti affetti da epatite cronica HCV-correlata. 58
Sindrome di Zollinger-Ellison associata a malattia celiaca: descrizione di un caso clinico. 58
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 57
Cause di malnutrizione nel paziente neoplastico 57
Chronic treatment with sylibin significantly improves insulin-resistance in patients with nonalcoholic fatty liver disease. 57
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 56
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 56
Obesità viscerale ed insulino-resistenza in corso di NASH. 55
Oligoelementi ed epatopatie: rapporti con la gravità di malattia e lo stato nutrizionale. 55
AISF position paper on liver disease and pregnancy 55
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 55
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 55
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 54
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 54
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 54
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 53
Effetto del trattamento cronico con sillibina sull’insulino-resistenza e sui marcatori plasmatici di fibrosi epatica in pazienti con malattia cronica di fegato. 53
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 53
Interazione tra alcol e cofattori sul rischio di cirrosi epatica. 53
Humerus metastasis from cholangiocarcinoma: a case report 52
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 52
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 52
Una spia sulla tavola dei nostri ragazzi 52
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 51
Activated protein C resistance in nonmetastatic gastric cancer patients. 51
Alcoholic liver disease and hepatitis C chronic infection 51
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 51
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 50
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 50
Alcohol consumption among young people in Italy: a “Facebook survey” 50
Emostasi e cancro dello stomaco non metastatico. 50
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 50
Alcohol intake and interferon therapy in patients with HCV-related chronic hepatitis. 49
Effect of Silybin in patients with chronic hepatitis: preliminary results of a multicentre randomized controlled trial vs placebo. 49
Sindrome di Zollinger-Ellison associata a malattia celiaca: descrizione di un caso clinico. 49
Marcatori di perossidazione lipidica nelle malattie croniche del fegato. 49
Effetti metabolici della silibina: studi in vitro e in vivo. 49
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 49
Gut microbiota and the liver 49
Steatoepatite non alcolica in pazienti con obesità viscerale. 48
Effetto della dieta sull’insorgenza della colelitiasi. 48
Escrezione urinaria di nitriti e nitroso-glutatione in soggetti con cirrosi epatica: rapporto con la gravità di malattia. 48
Fibrinogeno ed acido urico quali fattori di rischio cardiovascolare in pazienti obesi. 48
Diffusione intrafamiliare dell’infezione da Helicobacter pylori. 48
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 48
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 48
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 48
Prevalence of lesions detected at upper endoscopy: an Italian Survey. 47
Gastroenterology in Italian clinical practice. The RING Study: six years’ data from gastroenterology departments 47
Totale 6.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 41 34
2019/20202.090 394 366 49 39 335 85 397 111 113 89 87 25
2020/20212.835 225 20 321 205 374 32 392 316 39 388 364 159
2021/20222.238 95 20 27 67 784 32 54 61 88 64 204 742
2022/20234.584 448 120 49 373 454 373 17 304 2.228 44 81 93
2023/20241.537 155 69 78 151 686 169 55 58 35 68 13 0
Totale 16.199